Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 195.83

-0.7%

Dec 26 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: kha vu who wrote (26714)	12/1/1998 12:35:00 AM
From: Machaon	Read Replies (3) of 32384

<< The final approval is pending review of additional chemistry information submitted by the Company as requested by the FDA and upon final labeling agreement. >> Kha, thanks for posting the article. I hadn't picked up upon the fact that the chemistry info has already been furnished to the FDA. It sounds like it was fairly easy to come up with the data, especially since it only took a day or two. So, providing that the chemistry data satisfied the FDA request, the main issue is a labeling agreement. Hopefully the labeling won't be too restrictive. Ligand expects approval by the end of December, so I would think that approval is almost a slam dunk at this time. Panretin Gel approval will be delayed about one month, IMHO. Not too big a deal. But, as long as there is uncertainty hanging over the final approval, Mother Market will probably be cautious. Regards, Bob

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next